Mind-Body Chair Yoga for Functional Mobility in Individuals With Lipedema
NCT07917195, Not applicable, Not yet recruiting, Cynthia Beers
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Mind-Body Chair Yoga for Functional Mobility in Individuals With Lipedema | ClinicalTrials.gov |
| NCT number | NCT07917195 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 73 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Cynthia Beers | ClinicalTrials.gov |
| Conditions | Lipedema | ClinicalTrials.gov |
| Interventions | Mind-Body Chair Yoga + Support Group, Support Group | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Feasibility of the Remote Mind-Body Chair Yoga Intervention | Baseline to immediately post-intervention (7 weeks) and 3-month follow-up. | Feasibility will be assessed using recruitment, retention, adherence, intervention completion, and participant acceptability measures. Recruitment feasibility: number/percentage enrolled relative to those screened Retention: percentage completing the 7-week intervention Adherence: attendance and/or completion of prescribed sessions Intervention acceptability: participant ratings of satisfaction or acceptability will be measured using the Participant Program Acceptability Questionnaire. Scale is 1-5. 1= Strongly Disagree, 5 = Strongly Agree. Study completion: percentage completing baseline and post-intervention assessments Adverse events: number and type of events related to the intervention. This is measured by Post Class Check-In and Weekly Check-In. | ClinicalTrials.gov |
| Secondary | Change in Functional Mobility from Baseline to Post-Intervention | Baseline to immediately post-intervention (7 weeks) and 3-month follow-up. | Functional mobility will be assessed at baseline and post-intervention using the: Lower Extremity Functional Scale (LEFS) - Scale is 0-4. 0=Extreme Difficulty or Unable to Perform Activity. 4=No Difficulty Upper Extremity Functional Index (UEFI) - Scale is 0-4. 0=Extreme Difficulty or Unable to Perform Activity. 4=No Difficulty 30 Second Chair Stand Assessment - There is no rating for this. This is rated based on the number of chair-to-standing transitions within 30 seconds. The change in functional mobility from baseline to post-intervention will be compared between participants assigned to the mind-body chair yoga plus support group and those assigned to the support-group-only comparison group. | ClinicalTrials.gov |
| Secondary | Change in Mental Well-Being from Baseline to Post-Intervention | Baseline to immediately post-intervention (7 weeks) and 3-month follow-up. | Change in mental well-being will be assessed using the Lipedema Psychological Functioning Questionnaire in the study protocol. Scale is: 0-6. 0=Never, 6=Always Scores collected at baseline and post-intervention will be compared between the two study groups. | ClinicalTrials.gov |
| Secondary | Change in Pain Severity from Baseline to Post-Intervention | Baseline to immediately post-intervention (7 weeks) and 3-month follow-up. | Change in pain severity will be assessed using the Brief Pain Inventory. Scale is: 0 to 10 (depends on the question). Different options for zero can be no pain, no relief, or does not interfere. Ten equals pain as bad you can imagine, complete relief, or completely interferes. This is specified in the study protocol. Baseline and post-intervention scores will be compared between the two study groups. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 10
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)